Biomimetic nanoparticle loading obatoclax mesylate for the treatment of non-small-cell lung cancer (NSCLC) through suppressing Bcl-2 signaling

Song Chen(Wellcome Sanger Institute), Peng Duan(Sun Yat-sen University), Yujie Ren(Wuhan Institute of Virology)
Biomedicine & Pharmacotherapy
June 18, 2020
10.1016/j.biopha.2020.110371
Cited by 35

Related Papers

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells
|Cellular and Molecular Immunology|2020|514
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
|Immunity|2020|387
Plasma metabolomic and lipidomic alterations associated with COVID-19
|National Science Review|2020|367
SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts
|Virologica Sinica|2020|190
SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells
|Science China Life Sciences|2020|151